Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble-films.

@article{Strain2011InductionOO,
  title={Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble-films.},
  author={Eric C. Strain and Joseph A. Harrison and George E. Bigelow},
  journal={Clinical pharmacology and therapeutics},
  year={2011},
  volume={89 3},
  pages={443-9}
}
A sublingual soluble-film formulation of buprenorphine/naloxone (B/N) has been approved by the US Food and Drug Administration for the treatment of opioid dependency. This preparation provides unit-dose, child-resistant packaging amenable to tracking and accountability, offers more rapid dissolution, and has a potentially preferred taste vs. tablets. This… CONTINUE READING